<DOC>
	<DOCNO>NCT00951964</DOCNO>
	<brief_summary>Dystrophic epidermolysis bullosa hereditaria genodermatosis responsible formation cutaneous bullous lesion arise spontaneously mechanical trauma . These lesion due mutation gene COL7A1 cod collagen VII . There treatment available . Cares consist dress lesion protect skin . The investigator recently observe patient residual expression collagen VII phenotype severity modulate activation degree dermic metalloproteinase . The investigator also observe epigallocatechin-3-gallate ( Polyphenon EÂ® ) could regulate activity . The primary purpose study assess efficacity Polyphenon E decrease number cutaneous bullosa four month treatment . The primary outcome measure rate patient present decrease 20 % number cutaneous bullosa . Secondary outcome : severity mucosa impairment , affect cutaneous surface , average duration cicatrisation treatment tolerance . This study foresee inclusion 22 patient old 2 year old 5 center . When patient include , randomize receive treatment ( placebo ) 4 month .</brief_summary>
	<brief_title>Treatment Epidermolysis Bullosa Dystrophica Polyphenon E ( Epigallocatechin 3 Gallate )</brief_title>
	<detailed_description />
	<mesh_term>Epidermolysis Bullosa</mesh_term>
	<mesh_term>Epidermolysis Bullosa Dystrophica</mesh_term>
	<mesh_term>Epigallocatechin gallate</mesh_term>
	<criteria>know mutation COL7A1 tea drinker patient receive induction treatment , protease inhibitor treatment liver failure</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>